Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
26
RAPP Quote, Financials, Valuation and Earnings
Last price:
$30.17
Seasonality move
:
-47.31%
Day range:
$28.99 - $30.74
52-week range:
$6.43 - $42.27
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.15x
Volume:
221.9K
Avg. volume:
407.8K
1-year change:
56.64%
Market cap:
$1.1B
Revenue:
--
EPS (TTM):
-$2.69
Earnings Data
Next earnings date for RAPP
Mar 10
2026
Most recent earnings per share
-$0.71
Beat by $0.02
(Nov 6/2025)
Consensus Estimate
-$0.73
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RAPP Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/10/2026 | Q4 | -- | -- | -- | -$0.65 | -- |
| 11/06/2025 | Q3 | -- | -- | -$0.71 | -$0.73 | $0.02 |
| 08/08/2025 | Q2 | -- | -- | -$0.75 | -$0.77 | $0.02 |
| 05/15/2025 | Q1 | -- | -- | -$0.68 | -$0.75 | $0.06 |
| 03/11/2025 | Q4 | -- | -- | -$0.55 | -$0.70 | $0.15 |
| 11/07/2024 | Q3 | -- | -- | -$0.48 | -$0.52 | $0.04 |
| 08/08/2024 | Q2 | -- | -- | -$0.50 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.62 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.38 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.36 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.18 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.17 | -- | -- |
Rapport Therapeutics, Inc. Earnings Questions
-
How Much did Rapport Therapeutics, Inc. Generate in Revenue Last Quarter?
Rapport Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Rapport Therapeutics, Inc. Beat Earnings Last Quarter?
Rapport Therapeutics, Inc. announced earnings per share of -$0.71 which represents a beat of analyst forecast a -$0.73 per share.
-
Is Rapport Therapeutics, Inc. Profitable?
Rapport Therapeutics, Inc. reported -$256K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Rapport Therapeutics, Inc. EPS Next Year?
Rapport Therapeutics, Inc.'s earnings are forecast to decrease from -$2.14 per share to -$2.83 per share next year representing a decrease of -32.28%.
-
When is Rapport Therapeutics, Inc.'s Earnings Date?
Rapport Therapeutics, Inc.'s next earnings date is March 10, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
